Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules
- Language: English
- 128 Pages
- Published: April 2012
Neogenix Oncology Corporation-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.
Scope of the reports
Each Pipeline Report provides the user with real detail on a company’s pipeline.
In addition to business summaries, contact information, company details and selected financial data, each report also contains extensive information in tabular and graphical formats on a company’s product pipeline and disease hub classification.
Product details consist of complete descriptions, therapeutic indication, drug class, mechanism of action and clinical trial information. Every report also includes detail on a company’s deals and alliances and recent corporate news including key milestones.
- Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company’s research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.
--Products by Phase of Development
--Products by Disease Hub Classification
--Products by Indication